Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-04 Ives Jeffrey L. Director Grant or award · Stock Option (Right to Buy) +195,000 195,000
2024-06-04 Shiff Susan Ph.D. Director Grant or award +150,647 202,085
2024-06-04 Shiff Susan Ph.D. Director Grant or award · Stock Option (Right to Buy) +195,000 195,000
2024-06-04 VOGELBAUM MARTIN Director Grant or award +301,295 411,007
2024-06-04 VOGELBAUM MARTIN Director Grant or award · Stock Option (Right to Buy) +390,000 390,000
2024-05-02 Posner Christopher PRESIDENT AND CEO Sale −3,936 $0.75 $3K 176,585
2024-04-05 Goncalves Joana CHIEF MEDICAL OFFICER Sale −2,753 $0.83 $2K 53,365
2024-04-05 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sale −2,753 $0.83 $2K 88,247
2024-02-29 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sale −3,293 $0.89 $3K 91,000
2024-02-29 Posner Christopher PRESIDENT AND CEO Sale −5,834 $0.89 $5K 180,521
2024-02-29 Goncalves Joana CHIEF MEDICAL OFFICER Sale −3,293 $0.89 $3K 56,118
2024-02-08 Posner Christopher PRESIDENT AND CEO Sale −35,575 $0.53 $19K 186,355
2024-02-01 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Grant or award +13,500 102,063
2024-02-01 Maynard Ryan D CHIEF FINANCIAL OFFICER Grant or award +13,500 13,500
2024-02-01 Goncalves Joana CHIEF MEDICAL OFFICER Grant or award +13,500 67,181
2024-02-01 Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D Grant or award +13,500 167,247
2024-02-01 Posner Christopher PRESIDENT AND CEO Grant or award +62,500 226,911
2024-02-01 Posner Christopher PRESIDENT AND CEO Sale −4,981 $0.55 $3K 221,930
2023-11-02 Posner Christopher President and CEO Sale −3,796 $1.22 $5K 164,411
2023-08-03 Posner Christopher President and CEO Sale 10b5-1 −4,307 $3.07 $13K 168,207

Page 4 of 7 · 123 trades